As for LGG, it could prevent or extend the time of tumor progression in different ways, such as the potential regulation of IDH, reducing the production of reactive oxygen species or through the regulation of epigenetic modifiers; however, these possibilities should be further explored in future research. This evidence concerns the gene IDH1 and neoplasm.